About this Journal Submit a Manuscript Table of Contents
Advances in Urology
Volume 2013 (2013), Article ID 752382, 6 pages
http://dx.doi.org/10.1155/2013/752382
Clinical Study

Randomized Controlled Trial to Compare the Safety and Efficacy of Tamsulosin, Solifenacin, and Combination of Both in Treatment of Double-J Stent-Related Lower Urinary Symptoms

1Department of Urology, Suez Canal University, P.O. Box 224, Ismailia 41522, Egypt
2Department of Urology, King Khalid Hospital, P.O. Box 1985, Al-Kharj 11942, Saudi Arabia
3Department of Urology, Al-Azhar University, Nasr City, Cairo 11884, Egypt
4Department of Urology, Salman Bin Abdul-Aziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia
5Department of Urology, Faculty of Medicine, Zagazig University, P.O. Box 203, Zagazig 44519, Egypt
6Department of Urology, King Abdallah Hospital, P.O. Box 60, Bisha 61922, Saudi Arabia
7Department of Urology, Insurance Hospital, Ismailia 41528, Egypt

Received 2 June 2013; Accepted 7 September 2013

Academic Editor: James A. Brown

Copyright © 2013 Essam Shalaby et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. E. Knudsen, D. T. Beiko, and J. D. Denstedt, “Stenting after ureteroscopy: pros and cons,” Urologic Clinics of North America, vol. 31, no. 1, pp. 173–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. B. H. Chew, B. E. Knudsen, and J. D. Denstedt, “The use of stents in contemporary urology,” Current Opinion in Urology, vol. 14, no. 2, pp. 111–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. H. B. Joshi, A. Stainthorpe, F. X. Keeley Jr., R. Macdonagh, and A. G. Timoney, “Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis,” Journal of Endourology, vol. 15, no. 2, pp. 151–154, 2001. View at Scopus
  4. H. B. Joshi, N. Newns, A. Stainthorpe, R. P. MacDonagh, F. X. Keeley Jr., and A. G. Timoney, “Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure,” Journal of Urology, vol. 169, no. 3, pp. 1060–1064, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Sighinolfi, S. Micali, S. de Stefani et al., “Indwelling ureteral stents and sexual health: a prospective, multivariate analysis,” Journal of Urology, vol. 178, no. 1, pp. 229–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Thomas, “Indwelling ureteral stents: impact of material and shape on patient comfort,” Journal of Endourology, vol. 7, no. 2, pp. 137–140, 1993. View at Scopus
  7. C.-J. Wang, S.-W. Huang, and C.-H. Chang, “Effects of specific α-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study,” Urological Research, vol. 37, no. 3, pp. 147–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M.-S. Choo, J. Z. Lee, J. B. Lee et al., “Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study,” International Journal of Clinical Practice, vol. 62, no. 11, pp. 1675–1683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. J. Lee, K. H. Huang, H. J. Yang, H. C. Chang, J. Chen, and T. K. Yang, “Solifenacin improves double-J stent-related symptomsin both genders following uncomplicated ureteroscopic lithotripsy,” Urolithiasis, vol. 41, pp. 247–252, 2013. View at Publisher · View at Google Scholar
  10. K. Ugur, E. Bilal, T. Murat, F. Gokhan, T. Fatih, and O. Aydin, “Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms,” Canadian Urological Association Journal, vol. 6, no. 6, pp. 234–237, 2012.
  11. M. Shibasaki, K. Sudoh, O. Inagaki, W. Uchida, and K. Honda, “Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs,” Journal of Autonomic Pharmacology, vol. 12, no. 4, pp. 263–268, 1992. View at Scopus
  12. M. D. Vardy, H. D. Mitcheson, T.-A. Samuels et al., “Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT—a double-blind, placebo-controlled trial,” International Journal of Clinical Practice, vol. 63, no. 12, pp. 1702–1714, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C.-H. Ho, T.-C. Chang, H.-H. Lin, S.-P. Liu, K.-H. Huang, and H.-J. Yu, “Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms,” Journal of the Formosan Medical Association, vol. 109, no. 10, pp. 702–708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. B. Joshi, A. Stainthorpe, R. P. MacDonagh, F. X. Keeley Jr., and A. G. Timoney, “Indwelling ureteral stents: evaluation of symptoms, quality of life and utility,” Journal of Urology, vol. 169, no. 3, pp. 1065–1069, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. R. Byrne, B. K. Auge, J. Kourambas, R. Munver, F. Delvecchio, and G. M. Preminger, “Routine ureteral stenting is not necessary after ureteroscopy and ureteropyeloscopy: a randomized trial,” Journal of Endourology, vol. 16, no. 1, pp. 9–13, 2002. View at Scopus
  16. M. Duvdevani, B. H. Chew, and J. D. Denstedt, “Minimizing symptoms in patients with ureteric stents,” Current Opinion in Urology, vol. 16, no. 2, pp. 77–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Damiano, R. Autorino, M. de Sio, A. Giacobbe, I. M. Palumbo, and M. D'Armiento, “Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study,” Journal of Endourology, vol. 22, no. 4, pp. 651–655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Rane, A. Saleemi, D. Cahill, S. Sriprasad, N. Shrotri, and R. Tiptaft, “Have stent-related symptoms anything to do with placement technique?” Journal of Endourology, vol. 15, no. 7, pp. 741–745, 2001. View at Scopus
  19. D. T. Beiko, B. E. Knudsen, and J. D. Denstedt, “Advances in ureteral stent design,” Journal of Endourology, vol. 17, no. 4, pp. 195–199, 2003. View at Scopus
  20. M. D. Dunn, A. J. Portis, S. A. Kahn et al., “Clinical effectiveness of new stent design: randomized single-blind comparison of tail and double-pigtail stents,” Journal of Endourology, vol. 14, no. 2, pp. 195–202, 2000. View at Scopus
  21. C.-H. Ho, S.-C. Chen, S.-D. Chung et al., “Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms,” Journal of Endourology, vol. 22, no. 7, pp. 1427–1431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Damiano, R. Autorino, M. de Sio et al., “Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study,” European Urology, vol. 48, no. 4, pp. 673–678, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. B. H. Chew, B. E. Knudsen, L. Nott et al., “Pilot study of ureteral movement in stented patients: first step in understanding dynamic ureteral anatomy to improve stent comfort,” Journal of Endourology, vol. 21, no. 9, pp. 1069–1075, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Lang, M. E. Davidson, and B. Exintaris, “Pyeloureteral motility and ureteral peristalsis: essential role of sensory nerves and endogenous prostaglandins,” Experimental Physiology, vol. 87, no. 2, pp. 129–146, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. C.-J. Wang, S.-W. Huang, and C.-H. Chang, “Effects of tamsulosin on lower urinary tract symptoms due to double-j stent: a prospective study,” Urologia Internationalis, vol. 83, no. 1, pp. 66–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Agarwal, S. Dhiraaj, V. Singhal, R. Kapoor, and M. Tandon, “Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study,” British Journal of Anaesthesia, vol. 96, no. 3, pp. 377–380, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. K. T. Lim, Y. T. Kim, T. Y. Lee, and S. Y. Park, “Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts,” Korean Journal of Urology, vol. 52, no. 7, pp. 485–488, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. H. B. Joshi, A. Okeke, N. Newns, F. X. Keeley Jr., and A. G. Timoney, “Characterization of urinary symptoms in patients with ureteral stents,” Urology, vol. 59, no. 4, pp. 511–516, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Deliveliotis, M. Chrisofos, E. Gougousis, A. Papatsoris, A. Dellis, and I. M. Varkarakis, “Is there a role for alpha1-blockers in treating double-J stent-related symptoms?” Urology, vol. 67, no. 1, pp. 35–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Beddingfield, R. N. Pedro, B. Hinck, C. Kreidberg, K. Feia, and M. Monga, “Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study,” Journal of Urology, vol. 181, no. 1, pp. 170–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. U. Kuyumcuoglu, B. Eryildirim, M. Tuncer, G. Faydaci, F. Tarhan, and A. Ozgül, “Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms,” Canadian Urological Association Journa, vol. 6, no. 6, pp. E234–E237, 2012.
  32. R. D. Norris, R. L. Sur, W. P. Springhart et al., “A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort,” Urology, vol. 71, no. 5, pp. 792–795, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. S. C. Park, S. W. Jung, J. W. Lee, and J. S. Rim, “The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms,” Journal of Endourology, vol. 23, no. 11, pp. 1913–1917, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. K. T. Lim, Y. T. Kim, T. Y. Lee, and S. Y. Park, “Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts,” Korean Journal of Urology, vol. 52, no. 7, pp. 485–488, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. J. Lee, C. Yoo, C. Y. Oh et al., “Stent position is more important than α-blockers or anticholinergics for stent-related lower urinary tract symptoms after ureteroscopic ureterolithotomy: a prospective randomized study,” Korean Journal of Urology, vol. 51, no. 9, pp. 636–641, 2010. View at Publisher · View at Google Scholar · View at Scopus